Methotrexate and Tirzepatide (Mounjaro) Interaction
Methotrexate does not have a specific, documented drug–drug interaction with tirzepatide in the prescribing information for MOUNJARO. [1]
Mechanism Relevant to Drug Interactions
Tirzepatide delays gastric emptying and can affect absorption of concomitantly administered oral medications. [1]
Implication for Methotrexate Injections
The gastric-emptying interaction described for tirzepatide applies to oral medications. [1] Methotrexate administered by injection is not dependent on gastric emptying for absorption, so the primary interaction concern described for tirzepatide is unlikely to apply to injectable methotrexate. [1]
Practical Monitoring Considerations
If methotrexate is administered as an injection, no special adjustment is specifically recommended for the methotrexate–tirzepatide combination in the MOUNJARO labeling. [1] If methotrexate is taken orally (not injectable), monitoring may be appropriate because tirzepatide can alter absorption of oral drugs. [1]
When Additional Caution Is Appropriate
Additional clinical caution is generally warranted with tirzepatide when clinically significant gastrointestinal side effects or conditions affecting gastric emptying occur, since tirzepatide is associated with delayed gastric emptying. [1]
Information to Confirm With the Prescribing Clinician
Route and formulation of methotrexate (injectable vs oral), methotrexate dosing schedule, and the presence of significant gastrointestinal symptoms should be confirmed because the interaction warning specifically targets oral drug absorption. [1]